Campbell & Co Investment Adviser’s AngioDynamics ANGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-19,879
Closed -$407K 757
2022
Q3
$407K Buy
19,879
+5,475
+38% +$120K 0.09% 381
2022
Q2
$279K Buy
14,404
+1,349
+10% +$27.6K 0.08% 487
2022
Q1
$281K Sell
13,055
-4,700
-26% -$107K 0.08% 501
2021
Q4
$490K Sell
17,755
-400
-2% -$11K 0.17% 210
2021
Q3
$471K Sell
18,155
-1,500
-8% -$40.1K 0.15% 232
2021
Q2
$533K Buy
19,655
+9,400
+92% +$230K 0.22% 136
2021
Q1
$240K Buy
+10,255
New +$207K 0.15% 301
2019
Q4
Sell
-19,183
Closed -$353K 644
2019
Q3
$353K Buy
19,183
+5,092
+36% +$99.6K 0.13% 312
2019
Q2
$277K Sell
14,091
-20,202
-59% -$411K 0.13% 331
2019
Q1
$784K Buy
34,293
+17,553
+105% +$381K 0.39% 43
2018
Q4
$373K Sell
16,740
-1,871
-10% -$38.7K 0.37% 87
2018
Q3
$405K Sell
18,611
-5,100
-22% -$113K 0.28% 123
2018
Q2
$527K Buy
23,711
+7,300
+44% +$149K 0.41% 50
2018
Q1
$283K Buy
16,411
+2,383
+17% +$39.7K 0.24% 182
2017
Q4
$233K Buy
14,028
+1,684
+14% +$28.7K 0.17% 273
2017
Q3
$211K Sell
12,344
-2,846
-19% -$47.8K 0.17% 274
2017
Q2
$246K Buy
+15,190
New +$240K 0.23% 200

Other funds holding ANGO

Campbell & Co Investment Adviser's ANGO Position: Q4 2022 in Review

Campbell & Co Investment Adviser sold out of AngioDynamics (ANGO) in Q4 2022, closing a stake of 19,879 shares — an estimated $407K sold.

Campbell & Co Investment Adviser first reported a position in ANGO in Q2 2017 and held it in 17 quarters. The position peaked at $784K in Q1 2019. 149 funds tracked by Wall St. Rank hold ANGO as of Q4 2022.

  • Campbell & Co Investment Adviser reported no remaining AngioDynamics position as of Q4 2022 after selling out during the quarter.
  • Campbell & Co Investment Adviser sold 19,879 AngioDynamics shares in Q4 2022, an estimated $407K.
  • Campbell & Co Investment Adviser first reported a position in AngioDynamics in Q2 2017 and held it in 17 quarters.
  • Campbell & Co Investment Adviser's AngioDynamics position peaked at $784K in Q1 2019.
  • 149 funds tracked by Wall St. Rank held AngioDynamics as of Q4 2022.

Based on Campbell & Co Investment Adviser's 13F filing for Q4 2022, filed 14 Feb 2023.